These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9831198

  • 1. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
    Kapadia SB, Barnes L.
    Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M.
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors.
    Nasser SM, Faquin WC, Dayal Y.
    Am J Clin Pathol; 2003 Jun; 119(6):801-6. PubMed ID: 12817426
    [Abstract] [Full Text] [Related]

  • 8. Gross cystic disease fluid protein-15 in salivary gland tumors.
    Swanson PE, Pettinato G, Lillemoe TJ, Wick MR.
    Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
    [Abstract] [Full Text] [Related]

  • 9. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
    Delgado R, Klimstra D, Albores-Saavedra J.
    Cancer; 1996 Sep 01; 78(5):958-67. PubMed ID: 8780532
    [Abstract] [Full Text] [Related]

  • 10. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS, Cox CE, Wells SA, Paull D, Dilley WG, McCarty KS, Fetter BF, Glaubitz LC, McCarty KS.
    Surgery; 1982 Sep 01; 92(3):443-9. PubMed ID: 7202259
    [Abstract] [Full Text] [Related]

  • 11. Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation.
    Kawahara A, Harada H, Akiba J, Kage M.
    Diagn Cytopathol; 2008 Jul 01; 36(7):485-93. PubMed ID: 18528886
    [Abstract] [Full Text] [Related]

  • 12. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
    Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan CY.
    Mod Pathol; 2003 Dec 01; 16(12):1218-23. PubMed ID: 14681322
    [Abstract] [Full Text] [Related]

  • 13. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML, Longacre TA, Smoller BR.
    Mod Pathol; 1995 Dec 01; 8(9):897-901. PubMed ID: 8751328
    [Abstract] [Full Text] [Related]

  • 14. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
    Søreide JA, Lea OA, Kvinnsland S.
    Anticancer Res; 1991 Dec 01; 11(3):1323-6. PubMed ID: 1888167
    [Abstract] [Full Text] [Related]

  • 15. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.
    Yang RK, Zhao P, Lu C, Luo J, Hu R.
    Hum Pathol; 2019 Feb 01; 84():173-182. PubMed ID: 30267779
    [Abstract] [Full Text] [Related]

  • 16. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.
    Histopathology; 2007 Jun 01; 50(7):866-74. PubMed ID: 17543076
    [Abstract] [Full Text] [Related]

  • 17. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.
    Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, Ud Din N, Purgina B, Lai C, Griffith CC, Chiosea SI.
    Am J Surg Pathol; 2015 May 01; 39(5):705-13. PubMed ID: 25871467
    [Abstract] [Full Text] [Related]

  • 18. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH, Hecht JL, Pinkus JL, Pinkus GS.
    Am J Clin Pathol; 2002 May 01; 117(5):745-50. PubMed ID: 12090423
    [Abstract] [Full Text] [Related]

  • 19. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
    Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H.
    Cancer; 2003 Aug 15; 98(4):703-11. PubMed ID: 12910513
    [Abstract] [Full Text] [Related]

  • 20. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
    Fan CY, Wang J, Barnes EL.
    Am J Surg Pathol; 2000 Apr 15; 24(4):579-86. PubMed ID: 10757407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.